EH
WST icon

Equitable Holdings’s West Pharmaceutical WST Stock Holding History

Equitable Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
+1,420
New +$434K ﹤0.01% 1310
2024
Q4 		– Sell
-865
Closed -$260K – 1340
2024
Q3 		$260K Sell
865
-103
-11% -$31.5K ﹤0.01% 1090
2024
Q2 		$319K Sell
968
-116
-11% -$41K ﹤0.01% 974
2024
Q1 		$429K Sell
1,084
-39
-3% -$14.4K ﹤0.01% 853
2023
Q4 		$395K Buy
1,123
+95
+9% +$33.6K ﹤0.01% 845
2023
Q3 		$386K Sell
1,028
-5
-0.5% -$1.93K 0.01% 801
2023
Q2 		$395K Buy
1,033
+235
+29% +$84K 0.01% 770
2023
Q1 		$276K Buy
+798
New +$233K ﹤0.01% 823

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Equitable Holdings's WST Position: Q2 2026 in Review

Equitable Holdings opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,420 shares worth $510K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Equitable Holdings previously reported a position in WST as recently as Q3 2024.

Equitable Holdings first reported a position in WST in Q1 2023 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Equitable Holdings held 1,420 shares of West Pharmaceutical worth $510K as of Q2 2026.
  • West Pharmaceutical was a new Equitable Holdings position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1310 holding.
  • Equitable Holdings first reported a position in West Pharmaceutical in Q1 2023 and has held it in 8 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.